(Q51137886)

English

PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.

scientific article published on 26 November 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop. (English)

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

10

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

object named as

Jos G Bessems

1

0 references

Eva-Maria Collnot

8

object named as

Eva-Maria Collnot

1 reference

Europe PubMed Central

30 March 2018

Ursula Gundert-Remy

12

object named as

Ursula Gundert-Remy

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

7

object named as

Sandra Coecke

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

author name string

George Loizou

2

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

Kannan Krishnan

3

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

Harvey J Clewell

4

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

Camilla Bernasconi

5

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

Frederic Bois

6

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

Walter Diembeck

9

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

Liesbeth Geraets

11

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

Nynke Kramer

13

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

Gabriele Küsters

14

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

Sofia B Leite

15

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

Olavi R Pelkonen

16

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

Klaus Schröder

17

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

Emanuela Testai

18

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

Iwona Wilk-Zasadna

19

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

José-Manuel Zaldívar-Comenges

20

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

language of work or name

0 references

publication date

26 November 2013

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

Regulatory Toxicology and Pharmacology

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

68

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

1

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

119-139

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

Solubility properties in polymers and biological media. 2. The correlation and prediction of the solubilities of nonelectrolytes in biological tissues and fluids.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Physiologically based pharmacokinetic (PBPK) models for nasal tissue dosimetry of organic esters: assessing the state-of-knowledge and risk assessment applications with methyl methacrylate and vinyl acetate

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

The binding of drugs to hepatocytes and its relationship to physicochemical properties

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Quantitative structure-property relationships for physiologically based pharmacokinetic modeling of volatile organic chemicals in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Quantitative structure-property relationships for interspecies extrapolation of the inhalation pharmacokinetics of organic chemicals

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Enhanced metabolite identification with MS(E) and a semi-automated software for structural elucidation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Improving the applicability of (Q)SARs for percutaneous penetration in regulatory risk assessment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Application of a generic physiologically based pharmacokinetic model to the estimation of xenobiotic levels in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Application of a generic physiologically based pharmacokinetic model to the estimation of xenobiotic levels in rat plasma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Physiological parameter values for physiologically based pharmacokinetic models

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Predicting blood:air partition coefficients using basic physicochemical properties

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Physiologically based pharmacokinetic/toxicokinetic modeling.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Evaluation of physiologically based pharmacokinetic models for use in risk assessment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Development and specification of physiologically based pharmacokinetic models for use in risk assessment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Metabolism: a bottleneck in in vitro toxicological test development. The report and recommendations of ECVAM workshop 54

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Metabolites: structure determination and prediction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Pharmacophore modeling of cytochromes P450.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

A quantitative property-property relationship (QPPR) approach to estimate in vitro tissue-blood partition coefficients of organic chemicals in rats and humans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Towards quantitative prediction of oral drug absorption

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Evaluation of a physiologically-based pharmacokinetic approach for simulating the first-time-in-animal study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Development of a whole body physiologically based model to characterise the pharmacokinetics of benzodiazepines. 1: Estimation of rat tissue-plasma partition ratios

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Relative lipid content as the sole mechanistic determinant of the adipose tissue:blood partition coefficients of highly lipophilic organic chemicals

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

A modular approach to the ECVAM principles on test validity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Use of human in vitro skin models for accurate and ethical risk assessment: metabolic considerations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Structure-ADME relationship: still a long way to go?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Calculating the retention of volatile organic compounds in the lung on the basis of their physicochemical properties.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

A novel strategy for physiologically based predictions of human pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

An integrated QSPR-PBPK modelling approach for in vitro-in vivo extrapolation of pharmacokinetics in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Interspecies extrapolation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Computer systems for the prediction of xenobiotic metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics: towards the prediction of human p450 substrate specificity and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

An evaluation of mathematical models for predicting skin permeability

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Physiologically-based pharmacokinetic (PBPK) models in toxicity testing and risk assessment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Development of good modelling practice for physiologically based pharmacokinetic models for use in risk assessment: the first steps

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

The use of in vitro toxicity data and physiologically based kinetic modeling to predict dose-response curves for in vivo developmental toxicity of glycol ethers in rat and man.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Structure-based methods for the prediction of drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Development of quantitative structure-pharmacokinetic relationships

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Empirical relations predicting human and rat tissue:air partition coefficients of volatile organic compounds

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Relationship between Olive Oil:Air, Saline:Air, and Rat Brain:Air Partition Coefficients of Organic Solvents In Vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Physiologically based toxicokinetic modelling as a tool to support risk assessment: three case studies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Quantitative structure-permeability relationships (QSPRs) for percutaneous absorption

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Using structural information to create physiologically based pharmacokinetic models for all polychlorinated biphenyls

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Using structural information to create physiologically based pharmacokinetic models for all polychlorinated biphenyls. II. Rates of metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

From known knowns to known unknowns: predicting in vivo drug metabolites

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Prediction of dose-hepatotoxic response in humans based on toxicokinetic/toxicodynamic modeling with or without in vivo data: a case study with acetaminophen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

A unified algorithm for predicting partition coefficients for PBPK modeling of drugs and environmental chemicals

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

QSARs for PBPK modelling of environmental contaminants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Prediction of concentration-time profile and its inter-individual variability following the dermal drug absorption

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Toward a new paradigm for the efficient in vitro-in vivo extrapolation of metabolic clearance in humans from hepatocyte data

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

A biologically-based algorithm for predicting human tissue: blood partition coefficients of organic chemicals.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

A tissue composition-based algorithm for predicting tissue:air partition coefficients of organic chemicals.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

A mechanistic algorithm for predicting blood:air partition coefficients of organic chemicals with the consideration of reversible binding in hemoglobin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

An integrated QSAR-PBPK modelling approach for predicting the inhalation toxicokinetics of mixtures of volatile organic chemicals in the rat

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Tutorial on physiologically based kinetic modeling in molecular nutrition and food research.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Mechanistic approaches to volume of distribution predictions: understanding the processes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Computational modeling of aerosol deposition in respiratory tract: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Incorporating human dosimetry and exposure into high-throughput in vitro toxicity screening.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Fast Prediction of Cytochrome P450 Mediated Drug Metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

General approach for the calculation of tissue to plasma partition coefficients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Report from the EPAA workshop: in vitro ADME in safety testing used by EPAA industry sectors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Quantitative structure-pharmacokinetic relationships and drug design

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Skin-PAMPA: a new method for fast prediction of skin penetration.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Utility of physiologically based pharmacokinetic models to drug development and rational drug discovery candidate selection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

An assessment of the impact of physico-chemical and biochemical characteristics on the human kinetic adjustment factor for systemic toxicants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Elucidation of xenobiotic metabolism pathways in human skin and human skin models by proteomic profiling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Relative impact of incorporating pharmacokinetics on predicting in vivo hazard and mode of action from high-throughput in vitro toxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

High-throughput, computer assisted, specific MetID. A revolution for drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

In vitro test of nicotine's permeability through human skin. Risk evaluation and safety aspects.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

The rise of PAMPA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

PAMPA--a drug absorption in vitro model 13. Chemical selectivity due to membrane hydrogen bonding: in combo comparisons of HDM-, DOPC-, and DS-PAMPA models

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing - t4 report*.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Consumer product in vitro digestion model: Bioaccessibility of contaminants and its application in risk assessment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Transport of chlorpromazine in the Caco-2 cell permeability assay: a kinetic study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

In vitro models to evaluate the permeability of poorly soluble drug entities: challenges and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

In vivo validation of the unified BARGE method to assess the bioaccessibility of arsenic, antimony, cadmium, and lead in soils

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Monolayers of human alveolar epithelial cells in primary culture for pulmonary absorption and transport studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Determination and prediction of tissue-gas partition coefficients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Drug permeability across a phospholipid vesicle-based barrier 2. Characterization of barrier structure, storage stability and stability towards pH changes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Drug permeability across a phospholipid vesicle based barrier: 3. Characterization of drug-membrane interactions and the effect of agitation on the barrier integrity and on the permeability

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Drug permeability across a phospholipid vesicle-based barrier 4. The effect of tensides, co-solvents and pH changes on barrier integrity and on drug permeability

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Human respiratory epithelial cell culture for drug delivery applications

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

A methodology for solving physiologically based pharmacokinetic models without the use of simulation softwares.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Phase 1 and phase 2 drug metabolism and bile acid production of HepaRG cells in a bioartificial liver in absence of dimethyl sulfoxide

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Initial development of a solid-phase fugacity meter for semivolatile organic compounds

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Methods for predicting in vivo pharmacokinetics using data from in vitro assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Simulated intestinal fluid as transport medium in the Caco-2 cell culture model.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Absorption properties and P-glycoprotein activity of modified Caco-2 cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Application of a dynamic in vitro gastrointestinal tract model to study the availability of food mutagens, using heterocyclic aromatic amines as model compounds.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

A modified parallel artificial membrane permeability assay for evaluating the bioconcentration of highly hydrophobic chemicals in fish

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

In vitro and in vivo evaluation of the tissue-to-blood partition coefficient for physiological pharmacokinetic models

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Evolution of solid-phase microextraction technology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Drug-protein binding sites. New trends in analytical and experimental methodology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

In vitro-in vivo extrapolation of hepatic clearance: biological tools, scaling factors, model assumptions and correct concentrations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Canadian house dust study: lead bioaccessibility and speciation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Recent developments in solid-phase microextraction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Protocol for solid-phase microextraction method development

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Interindividual variability in gene expression profiles in human hepatocytes and comparison with HepaRG cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Functional expression, inhibition and induction of CYP enzymes in HepaRG cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Solid-phase microextraction in biomedical analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Development and validation of a higher-throughput equilibrium dialysis assay for plasma protein binding.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.11.008

7 January 2021

Identifiers

10.1016/J.YRTPH.2013.11.008

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/24287156

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51137886&oldid=1555297192"